Literature DB >> 28710326

Cortical influences drive amyotrophic lateral sclerosis.

Andrew Eisen1, Heiko Braak2, Kelly Del Tredici2, Roger Lemon3, Albert C Ludolph4, Matthew C Kiernan5.   

Abstract

The early motor manifestations of sporadic amyotrophic lateral sclerosis (ALS), while rarely documented, reflect failure of adaptive complex motor skills. The development of these skills correlates with progressive evolution of a direct corticomotoneuronal system that is unique to primates and markedly enhanced in humans. The failure of this system in ALS may translate into the split hand presentation, gait disturbance, split leg syndrome and bulbar symptomatology related to vocalisation and breathing, and possibly diffuse fasciculation, characteristic of ALS. Clinical neurophysiology of the brain employing transcranial magnetic stimulation has convincingly demonstrated a presymptomatic reduction or absence of short interval intracortical inhibition, accompanied by increased intracortical facilitation, indicating cortical hyperexcitability. The hallmark of the TDP-43 pathological signature of sporadic ALS is restricted to cortical areas as well as to subcortical nuclei that are under the direct control of corticofugal projections. This provides anatomical support that the origins of the TDP-43 pathology reside in the cerebral cortex itself, secondarily in corticofugal fibres and the subcortical targets with which they make monosynaptic connections. The latter feature explains the multisystem degeneration that characterises ALS. Consideration of ALS as a primary neurodegenerative disorder of the human brain may incorporate concepts of prion-like spread at synaptic terminals of corticofugal axons. Further, such a concept could explain the recognised widespread imaging abnormalities of the ALS neocortex and the accepted relationship between ALS and frontotemporal dementia. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  Amyotrophic lateral sclerosis; MRI; TDP-43; corticomotoneuron; neuropathology; neurophysiology; proteinopathy

Mesh:

Year:  2017        PMID: 28710326     DOI: 10.1136/jnnp-2017-315573

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  41 in total

1.  Functional up-regulation of the M-current by retigabine contrasts hyperexcitability and excitotoxicity on rat hypoglossal motoneurons.

Authors:  Filippo Ghezzi; Laura Monni; Andrea Nistri
Journal:  J Physiol       Date:  2018-05-30       Impact factor: 5.182

Review 2.  Olfactory Dysfunction in Neurodegenerative Diseases.

Authors:  Concepció Marin; Dolores Vilas; Cristóbal Langdon; Isam Alobid; Mauricio López-Chacón; Antje Haehner; Thomas Hummel; Joaquim Mullol
Journal:  Curr Allergy Asthma Rep       Date:  2018-06-15       Impact factor: 4.806

3.  Motor neuron disease in 2017: Progress towards therapy in motor neuron disease.

Authors:  Matthew C Kiernan
Journal:  Nat Rev Neurol       Date:  2018-01-19       Impact factor: 42.937

Review 4.  Diagnostics of Amyotrophic Lateral Sclerosis: Up to Date.

Authors:  Ivana Štětkářová; Edvard Ehler
Journal:  Diagnostics (Basel)       Date:  2021-02-03

5.  Estrogen Enhances Dendrite Spine Function and Recovers Deficits in Neuroplasticity in the prpTDP-43A315T Mouse Model of Amyotrophic Lateral Sclerosis.

Authors:  Emily E Handley; Laura A Reale; Jyoti A Chuckowree; Marcus S Dyer; Grace L Barnett; Courtney M Clark; William Bennett; Tracey C Dickson; Catherine A Blizzard
Journal:  Mol Neurobiol       Date:  2022-03-06       Impact factor: 5.682

Review 6.  Recent advances in the diagnosis and prognosis of amyotrophic lateral sclerosis.

Authors:  Stephen A Goutman; Orla Hardiman; Ammar Al-Chalabi; Adriano Chió; Masha G Savelieff; Matthew C Kiernan; Eva L Feldman
Journal:  Lancet Neurol       Date:  2022-03-22       Impact factor: 59.935

Review 7.  The Cortical "Upper Motoneuron" in Health and Disease.

Authors:  Roger N Lemon
Journal:  Brain Sci       Date:  2021-05-12

Review 8.  Cortical Excitability across the ALS Clinical Motor Phenotypes.

Authors:  Thanuja Dharmadasa
Journal:  Brain Sci       Date:  2021-05-28

9.  Progressive arm muscle weakness in ALS follows the same sequence regardless of onset site: use of TOMS, a novel analytic method to track limb strength.

Authors:  Nimish J Thakore; Brian J Drawert; Brittany R Lapin; Erik P Pioro
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2021-02-23       Impact factor: 3.528

10.  Getting the upper hand in ALS.

Authors:  Clive N Svendsen
Journal:  Gene Ther       Date:  2022-01-20       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.